Name: Jiangxi Biological Products Research Institute Co., Ltd.
Address: National Jinggangshan Economic and Technological Development Zone, Ji'an City, Jiangxi Province
Drug quality inspection announcement
According to the requirements of the National Drug Testing and Quarantine Program in 2004, the State Food and Drug Administration organized a force to conduct follow-up tests on the relevant varieties of unqualified pharmaceutical manufacturers in the 2003 Quality Announcement, and conducted supervision and inspection on some drugs and biological products. The results of the test will be announced:
The current drug sampling inspection involved 71 varieties and 221 batches of 92 production enterprises, including 2 varieties and 5 batches of 4 production enterprises were unqualified (see Tables 1 and 2); The supervision and inspection involves a total of 3 categories, 21 varieties and 128 batches (see Tables 3 and 4).
For the unqualified drugs in the announcement, the drug supervision and administration department will investigate and deal with the inferior drugs in accordance with the relevant provisions of the Drug Administration Law, and the China National Institute for the Control of Pharmaceutical and Biological Products will continue to follow the tests.
Equipment auction bidding announcement